Details for Patent: 6,916,941
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 6,916,941 protect, and when does it expire?
Patent 6,916,941 protects LEXAPRO and is included in one NDA.
Protection for LEXAPRO has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifty-six patent family members in thirty-eight countries.
Summary for Patent: 6,916,941
Title: | Crystalline composition containing escitalopram |
Abstract: | Crystalline particles of escitalopram oxalate with a particle size of at least 40 .mu.m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed. |
Inventor(s): | Christensen; Troels Volsgaard (Holb.ae butted.k, DK), Liljegren; Ken (V.ae butted.rl.o slashed.se, DK), Elema; Michiel Onne (K.o slashed.bnhavn .O slashed., DK), Andresen; Lene (R.o slashed.dovre, DK), Mahashabde; Shashank (Kendall Park, NJ), Assenza; Sebastian P. (Fort Salonga, NY) |
Assignee: | H. Lundbeck A/S (Valby-Copenhagen, DK) |
Application Number: | 10/403,453 |
Patent Claim Types: see list of patent claims | Compound; Use; Formulation; Dosage form; Composition; |
Drugs Protected by US Patent 6,916,941
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-001 | Aug 14, 2002 | AB | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Allergan | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-002 | Aug 14, 2002 | AB | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Allergan | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-003 | Aug 14, 2002 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,916,941
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Denmark | PA 2001 01164 | Jul 31, 2001 |
International Family Members for US Patent 6,916,941
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 034898 | See Plans and Pricing | |||
Austria | 286730 | See Plans and Pricing | |||
Austria | 352546 | See Plans and Pricing | |||
Australia | 2002355624 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |